Loading...
HO1 logo

Hologic, Inc.DB:HO1 Stock Report

Market Cap €14.7b
Share Price
€65.00
n/a
1Yn/a
7D0%
Portfolio Value
​
View

Hologic, Inc.

DB:HO1 Stock Report

Market Cap: €14.7b

Hologic (HO1) Stock Overview

Engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. More details

HO1 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Rewards

Trading at 34.3% below our estimate of its fair value

Earnings are forecast to grow 13.88% per year

Risk Analysis

Shares are highly illiquid

Large one-off items impacting financial results


HO1 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

Hologic, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Hologic
Historical stock prices
Current Share PriceUS$65.00
52 Week HighUS$65.50
52 Week LowUS$45.00
Beta0.73
1 Month Change2.36%
3 Month Change2.36%
1 Year Changen/a
3 Year Changen/a
5 Year Change2.69%
Change since IPO279.56%

Recent News & Updates

Recent updates

Shareholder Returns

HO1DE Medical EquipmentDE Market
7D0%-0.7%-0.5%
1Yn/a-31.1%-3.6%

Return vs Industry: Insufficient data to determine how HO1 performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how HO1 performed against the German Market.

Price Volatility

Is HO1's price volatile compared to industry and market?
HO1 volatility
HO1 Average Weekly Movementn/a
Medical Equipment Industry Average Movement6.0%
Market Average Movement6.0%
10% most volatile stocks in DE Market14.1%
10% least volatile stocks in DE Market2.7%

Stable Share Price: HO1's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine HO1's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19857,070Steve MacMillanwww.hologic.com

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth.

Hologic, Inc. Fundamentals Summary

How do Hologic's earnings and revenue compare to its market cap?
HO1 fundamental statistics
Market cap€14.67b
Earnings (TTM)€472.24m
Revenue (TTM)€3.58b
31.1x
P/E Ratio
4.1x
P/S Ratio

Is HO1 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HO1 income statement (TTM)
RevenueUS$4.13b
Cost of RevenueUS$1.64b
Gross ProfitUS$2.49b
Other ExpensesUS$1.95b
EarningsUS$543.80m

Last Reported Earnings

Dec 27, 2025

Next Earnings Date

n/a

Earnings per share (EPS)2.44
Gross Margin60.38%
Net Profit Margin13.18%
Debt/Equity Ratio47.8%

How did HO1 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/28 06:49
End of Day Share Price 2026/03/20 00:00
Earnings2025/12/27
Annual Earnings2025/09/27

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Hologic, Inc. is covered by 40 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Charles ButlerBarclays
Charley JonesBarrington Research Associates, Inc.